Barclays PLC 13F Portfolio

The biggest buys aren’t obscure stock picks; they’re blunt instruments aimed at global growth and AI’s infrastructure layer.

• EEM: boosting the position to 20.3% is a statement that EM beta is the core macro call, with the fund adding about $14.7B despite already being up 18.6% versus cost.
• QQQ and SPY: adding QQQ by +246.1% and SPY by 5.3% shifts some AI upside into liquid, diversified tech and market exposure rather than doubling down on any one name.
• SMH: a +613.0% move into the semiconductor ETF (about $767.4M more) shows they still want AI and semi exposure, but in a basket that captures the whole supply chain.
• SNPS, TXN, NXPI, MRVL, KLAC, LRCX: incremental adds to design software, analog, and equipment underscore a preference for the "picks-and-shovels" of AI and auto/industrial semi demand.
• TSLA, V, BAC, C, GS, UNH, AZN: adding to Tesla, payments, big banks, and select health-care names suggests a secondary thesis: a reflationary, still-growing world where consumers keep spending, credit holds, and healthcare demand is durable.

The rising-conviction pattern is concentration in big liquid wrappers plus selective leverage to long-cycle beneficiaries, not hero trades in narrow stories.

Funding for this risk-on reshuffle comes from exactly where you’d expect: the prior cycle’s darlings and high-quality ballast.

• Nvidia, AMD, AVGO, Intel, TSM, AMAT, ADI, QCOM, PANW: across the AI and semi royalty stack, Barclays is realizing very large gains — Nvidia at roughly +194.0% vs cost, AMD at +354.9%, AVGO at +221.1%, Intel at +225.2%. They’re not walking away from semis; they’re moving from concentrated winners into broad exposure and tools.
• Alphabet (both lines), Apple, Microsoft, Meta, Amazon: the mega-platform complex is being consistently trimmed, with double-digit cuts to many, even as most sit 80–160% above cost. This is classic profit-taking, not a structural abandonment of Big Tech.
• WMT, COST, NFLX, CAT, AEP, utilities and staples-like defensives: sizable reductions in Walmart, Costco, Netflix, Caterpillar and American Electric Power shrink the defensive, late-cycle and "bond proxy" parts of the book.
• LLY, JNJ, ABBV, MRK: across pharma they’re generally lightening up, even with strong gains, while selectively adding where they see better risk/reward (UNH, AZN).

The sales read as a funding list: high-multiple winners and low-vol stalwarts are being cashed in to underwrite a bigger bet on EM, semis-as-a-basket, and cyclical financials.

On paper, tech’s weight falls from 48.76% to 41.63%, but that understates how radical the internal mix has changed.

Within technology and related exposures, they’re pivoting from a handful of outsized AI winners toward broad semi baskets (SMH) and diversified tech indices (QQQ), while still nurturing core positions in the equipment and design names (KLAC, LRCX, TXN, MRVL, SNPS). The theme isn’t "less AI" so much as "less single-name catastrophe risk if one AI leader stumbles."

The unclassified bucket jumps from 30.4% to 39.19%, almost entirely driven by EEM and the ETF complex (SPY, QQQ, VOO, SMH). That’s the real story: index and theme wrappers becoming the backbone of the book.

Outside tech and wrappers, changes are subtle but telling: Finance edges slightly higher via more BAC, C and GS; Real payments (Visa, Mastercard) inch up; Health Care, Consumer Discretionary, Utilities, and Industrials all drift down as they trim defensives and some US cyclicals. Overall, the sector chart shows a book leaning away from US defensives and mega-cap tech and toward EM-heavy, liquidity-friendly beta.

Put together, this quarter says Barclays wants to be paid if the world stays loud: EM currencies stabilizing or strengthening, global trade and capex humming, and AI demand remaining a multi-year build-out rather than a 2025 fad.

They’ve explicitly swapped some idiosyncratic US tech and defensive ballast for three exposures: emerging markets via EEM, all-weather US beta via SPY/VOO, and full-stack semis via SMH plus picks-and-shovels like SNPS, KLAC, LRCX and TXN. The add to TSLA and the quiet build in banks and payments reinforce a pro-cyclical stance.

If that macro view is right — soft-ish landing, persistent AI capex, EM catching a bid — this portfolio will behave like a high-octane benchmark-plus book, with outsized upside in EM and semis. If the world rolls over or the AI cycle disappoints, the trims in defensives and mega-cap tech mean less ballast than in prior quarters. The message in the 13F is unambiguous: Barclays is trading some resilience for more participation in the next leg of global growth.